Technical Analysis for MNKD - MannKind Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 4.18 | 2.45% | 0.10 |
MNKD closed up 2.45 percent on Friday, April 19, 2024, on 57 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 200 DMA | Bullish | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 200 DMA | Bearish | 2.45% | |
| Oversold Stochastic | Weakness | 2.45% | |
| Crossed Above 200 DMA | Bullish | 1.95% | |
| Stochastic Buy Signal | Bullish | 1.95% | |
| Doji - Bullish? | Reversal | 1.95% | |
| Outside Day | Range Expansion | 1.95% | |
| Oversold Stochastic | Weakness | 1.95% | |
| Fell Below 200 DMA | Bearish | 3.21% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 3 hours ago |
| 200 DMA Resistance | about 7 hours ago |
| Up 2% | about 7 hours ago |
| Up 1% | about 7 hours ago |
| Rose Above 200 DMA | about 8 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Organ Systems Boat Diabetes Therapeutic Products Insulin Endocrine System Hyperglycemia Inhaler
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Organ Systems Boat Diabetes Therapeutic Products Insulin Endocrine System Hyperglycemia Inhaler
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.75 |
| 52 Week Low | 3.17 |
| Average Volume | 3,164,948 |
| 200-Day Moving Average | 4.10 |
| 50-Day Moving Average | 4.26 |
| 20-Day Moving Average | 4.40 |
| 10-Day Moving Average | 4.22 |
| Average True Range | 0.21 |
| RSI (14) | 45.36 |
| ADX | 18.31 |
| +DI | 17.71 |
| -DI | 25.33 |
| Chandelier Exit (Long, 3 ATRs) | 4.48 |
| Chandelier Exit (Short, 3 ATRs) | 4.60 |
| Upper Bollinger Bands | 4.93 |
| Lower Bollinger Band | 3.86 |
| Percent B (%b) | 0.3 |
| BandWidth | 24.38 |
| MACD Line | -0.08 |
| MACD Signal Line | -0.03 |
| MACD Histogram | -0.0515 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.45 | ||||
| Resistance 3 (R3) | 4.43 | 4.31 | 4.41 | ||
| Resistance 2 (R2) | 4.31 | 4.24 | 4.33 | 4.39 | |
| Resistance 1 (R1) | 4.25 | 4.20 | 4.28 | 4.27 | 4.37 |
| Pivot Point | 4.13 | 4.13 | 4.15 | 4.15 | 4.13 |
| Support 1 (S1) | 4.07 | 4.06 | 4.10 | 4.09 | 3.99 |
| Support 2 (S2) | 3.95 | 4.02 | 3.97 | 3.97 | |
| Support 3 (S3) | 3.89 | 3.95 | 3.96 | ||
| Support 4 (S4) | 3.91 |
